What Determines Cross-Country Access to Antiretroviral Treatment?

Journal Article

2006

Permanent link to this Item
http://hdl.handle.net/11427/19852
 http://onlinelibrary.wiley.com/doi/10.1111/j.1467-7679.2006.00327.x/abstract
Files
Nattrass_What_Determines_Cross_2006.pdf (230.2 KB)
Authors
Nattrass, Nicoli
Journal Title

Development Policy Review

Link to Journal
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1467-7679/
Journal ISSN
Volume Title
Publisher

Wiley

Publisher

University of Cape Town

Department
Centre for Social Science Research(CSSR)
Faculty
Faculty of Humanities
License
Series
Abstract
Despite the recent international effort to expand access to highly active antiretroviral therapy (HAART) in developing countries, its coverage still varies significantly from country to country and is strongly correlated with per capita income. However, regional and political variables are also important. Cross-country regressions indicate that, controlling for political and economic characteristics and the scale of the HIV epidemic, Latin American and African countries have better coverage than predicted. Whereas the level of HIV prevalence was a significantly (negative) factor when accounting for HAART coverage in June 2004, this effect had disappeared by December 2004. The improvement appears to have benefited democratic countries in particular.
Description
Keywords
Antiretroviral Treatment

Reference:

Nattrass, N. (2006). What Determines Cross‐Country Access to Antiretroviral Treatment?. Development Policy Review, 24(3), 321-337.

Collections
Journal Articles